Sagespring Wealth Partners’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.56M Buy
29,703
+4,722
+19% +$1.31M 0.1% 115
2026
Q1
$7.38M Sell
24,981
-3,986
-14% -$1.18M 0.13% 91
2025
Q4
$7.91M Buy
28,967
+1,409
+5% +$383K 0.14% 87
2025
Q3
$7.45M Buy
27,558
+2,143
+8% +$583K 0.15% 80
2025
Q2
$7.01M Buy
25,415
+997
+4% +$271K 0.15% 78
2025
Q1
$6.48M Buy
24,418
+52
+0.2% +$12.8K 0.16% 74
2024
Q4
$5.66M Buy
+24,366
New +$5.6M 0.15% 67

Other funds holding CME

Sagespring Wealth Partners's CME Position: Q2 2026 in Review

Sagespring Wealth Partners increased its CME Group (CME) stake by 19% in Q2 2026, buying an estimated $1.31M and bringing the position to 29,703 shares worth $6.56M. The position accounts for 0.1% of the portfolio, ranked #115.

Sagespring Wealth Partners first reported a position in CME in Q4 2024 and has held it in 7 quarters since. The position peaked at $7.91M in Q4 2025. 1,706 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Sagespring Wealth Partners held 29,703 shares of CME Group worth $6.56M as of Q2 2026.
  • Sagespring Wealth Partners bought 4,722 CME Group shares in Q2 2026, an estimated $1.31M.
  • CME Group made up 0.1% of Sagespring Wealth Partners's portfolio in Q2 2026, its #115 holding.
  • Sagespring Wealth Partners first reported a position in CME Group in Q4 2024 and has held it in 7 quarters since.
  • Sagespring Wealth Partners's CME Group position peaked at $7.91M in Q4 2025.
  • 1,706 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Sagespring Wealth Partners's 13F filing for Q2 2026, filed 3 Aug 2026.